| Dr Robert Brandt Fick, Jr, MD | |
|
Palo Alto Va Health Care System, 3801 Miranda Avenue, Pulmonary & Ccm, Palo Alto, CA 94344 | |
| (650) 493-5000 | |
| Not Available |
| Full Name | Dr Robert Brandt Fick, Jr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | Palo Alto Va Health Care System, Palo Alto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811057086 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | G75955 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Brandt Fick, Jr, MD 240 Mimosa Way, Portola Valley, CA 94028 Ph: (650) 233-0647 | Dr Robert Brandt Fick, Jr, MD Palo Alto Va Health Care System, 3801 Miranda Avenue, Pulmonary & Ccm, Palo Alto, CA 94344 Ph: (650) 493-5000 |
News Archive
Rates of acute pancreatitis (inflammation of the pancreas) have doubled over the past 30 years, particularly among younger age groups, finds a study in this week's BMJ.
The latest results from an expedition to Mount Everest that looked at the body's response to low oxygen levels suggest that drugs or procedures that promote the body's production of a chemical compound called nitric oxide (NO) could improve the recovery of critically ill patients in intensive care.
Octapharma USA has received confirmation of orphan drug exclusivity from the U.S. Food and Drug Administration for wilate (von Willebrand Factor/Factor VIII Concentrate, Human), the replacement therapy developed specifically for von Willebrand Disease. The approval comes from the FDA Office of Orphan Products Development, which helps to advance the development of products that demonstrate promise for the treatment of rare diseases.
Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new drug delivery system using nanodiamonds (NDs) that allows for direct application of chemotherapy to brain tumors with fewer harmful side effects and better cancer-killing efficiency than existing treatments.
Persons who have developed positive attitudes towards life and aging are less likely to develop dementia finds a new study. Becca Levy from the Yale School of Public Health, USA, and colleagues have published the reports of this encouraging study in the latest issue of the journal PLOS ONE.
› Verified 1 days ago
Daniel Joseph Razzano, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Mahnoosh Kuhbanani Seifoddini, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Va Palo Alto Health Care System (111stc), Palo Alto, CA 94304 Phone: 209-946-3400 | |
Dr. Yusra Nazar Hussain, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 770 Welch Rd, Suite # 250, Palo Alto, CA 94304 Phone: 650-328-1676 Fax: 650-445-0911 | |
Christopher Demuth Sharp, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 900 Blake Wilbur Dr, Palo Alto, CA 94304 Phone: 650-723-6028 Fax: 650-725-7078 | |
Dr. David Yao, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Medical Services (111a), Palo Alto, CA 94304 Phone: 650-493-5000 | |
Dr. Franklin Perry, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2175 Park Blvd, Palo Alto, CA 94306 Phone: 650-330-3688 Fax: 650-330-3686 | |
Dr. Ryan Arthur Mcconnell, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2972 |